Testimony Opposing SB 1642 (AI Regulation) 3.27.25

TAHP opposes SB 1642, which replaces the single-commissioner model at TDI with a three-member panel, citing concerns over bureaucracy, slower responsiveness, and potential conflicts of interest. A single commissioner ensures swift, consistent decision-making, while a panel could introduce delays and regulatory inefficiencies. Including health care professionals in the commission may also undermine neutrality, affecting public trust in TDI’s oversight.

Click here to view TAHP’s testimony in response to SB 1642.

Become a Member

Membership with TAHP is an invaluable tool for integrating, building relationships, exchanging information and best practices, and promoting your services. You will be well-armed with the most timely and accurate information, strong relationships with key Texas leaders, and access to seasoned policy and regulatory experts.